Stockholm - Delayed Quote SEK

Xbrane Biopharma AB (publ) (XBRANE.ST)

Compare
0.2150 +0.0350 (+19.44%)
At close: 5:29 PM GMT+2
All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating Cash Flow
-419,273.0000
-406,678.0000
-193,918.0000
-219,610.0000
-238,407.0000
--
Investing Cash Flow
-11,411.0000
-16,769.0000
-60,125.0000
-77,350.0000
-3,855.0000
--
Financing Cash Flow
192,688.0000
298,696.0000
148,864.0000
349,365.0000
322,724.0000
--
End Cash Position
77,644.0000
65,402.0000
193,994.0000
295,180.0000
243,139.0000
--
Capital Expenditure
-11,411.0000
-16,769.0000
-60,125.0000
-77,350.0000
-3,855.0000
--
Issuance of Capital Stock
337,260.0000
120,018.0000
170,551.0000
380,870.0000
346,447.0000
--
Issuance of Debt
50,000.0000
225,000.0000
--
--
--
--
Repayment of Debt
-133,332.0000
-20,833.0000
--
--
-12.0000
--
Free Cash Flow
-430,684.0000
-423,447.0000
-254,043.0000
-296,960.0000
-242,262.0000
--
12/31/2019 - 2/3/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers